Novel approaches for targeting BRCA2-deficient tumour cells
Defects in homologous recombination (HR) repair are associated with significant mortality and improved therapies for HR-deficient tumours are therefore urgently needed. This work aimed to address this unmet need and utilised pharmacological approaches to investigate several methods for the targeting...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.712419 |